When combining the AD biomarker panel with the TTR isoform analysis requiring 2 out of 3 parameters of the AD-panel to be abnormal or the amount of non-modified TTR to be below <72 for the AD diagnosis, the diagnostic sensitivity for AD versus the NPH and HC groups was improved to 86% at a specificity of 82%. The gene discussed is TTR; the disease is Alzheimer disease.